Physician profile
Daniel F Smith
NPI 1912992843
$1,866.03
in general payments reported to CMS, 2019-2025
18 companies · $14.78 in 2025
The $14.78 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $315 · 2020: $67.50 · 2021: $201 · 2022: $360 · 2023: $591 · 2024: $316 · 2025: $14.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $921.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $391.01 | 2019-2024 | Skyrizi |
| Novartis Pharmaceuticals Corporation | $374.41 | 2019-2024 | |
| Janssen Biotech, INC. | $232.35 | 2019-2023 | Tremfya |
| Lilly USA, LLC | $226.24 | 2019-2024 | Taltz, Olumiant, Zepbound |
| Sun Pharmaceutical Industries INC. | $202.25 | 2023-2024 | Ilumya |
| Ucb, INC. | $107.34 | 2023-2024 | Bimzelx, Cimzia |
| Pfizer INC. | $67.43 | 2022-2024 | |
| Amgen INC. | $63.84 | 2019-2023 | Otezla |
| Regeneron Healthcare Solutions, INC. | $37.59 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.66 | 2023 | Spevigo |
| Genzyme Corporation | $21.36 | 2022 | |
| Dexcom, INC. | $18.21 | 2024 | Dexcom G6 Transmitter |
| Dusa Pharmaceuticals, INC. | $17.35 | 2019 | |
| Organon LLC | $15.09 | 2024 | |
| Elekta, INC. | $14.78 | 2025 | Flexitron Hdr |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $13.92 | 2023 | |
| Paratek Pharmaceuticals, INC. | $13.87 | 2022 | |
| Dermira, INC. | $13.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.